A reversible parkinsonian syndrome and hepatotoxcity following addition of carbamazepine to sodium valproate.
Department of Medicine, Austin Hospital, Melbourne, Vic.
P R
PR
Froomes
M R
MR
Stewart
D000368:Aged; D002220:Carbamazepine / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D002779:Cholestasis / Q000139:chemically induced / Q000175:diagnosis; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004830:Epilepsy, Tonic-Clonic / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis; D014635:Valproic Acid / Q000009:adverse effects*
D002220:Carbamazepine; D014635:Valproic Acid